Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
General Dynamics: Still Room To Run — A Tactical Long with Defined Risk/Reward
Defense momentum + steady cash flow; entry band, stops and multi-stage targets for a swing trade.
General Dynamics (GD) trades in the mid-$300s after a strong 2025 run. The business mixes durable defense backlog (marine, combat systems, technologie...
Vistra's Growth Path Is Real but Not Cheap - A Tactical Long with Tight Risk Control
Operational scale and new PPAs give earnings visibility; balance sheet and valuation call for a measured, swing-long approach.
Vistra (VST) is riding a favorable mix of nuclear PPAs and a gas-heavy acquisition toward steadier earnings. Recent quarters show robust operating cas...
FuboTV: Cheap, Volatile, and Priced For No Deal - Hulu Upside Not Reflected
Small-cap streaming trade — buy the rumor/optionality around Hulu synergy potential; size for volatility.
FuboTV (FUBO) trades at roughly $2.31 (01/29/2026) with an implied market cap near $790M and a stretched cost base. Recent corporate results show reve...
ASE Technology - Ride the Advanced Packaging Wave Backed by AI Demand
An actionable long trade: entry 19.0-20.0, stop 17.00, targets 24 and 29 — position horizon as AI-driven heterogenous integration ramps.
ASE Technology (ASX) has moved from a cyclical packaging play into the center of the AI hardware value chain. Recent price action (~$19.78) reflects a...
Public Storage: Buy the Slow Patch — High Cash Flow, Big Yield, Patient Upside
A defensive REIT with durable cash flow that offers an attractive entry during a temporary earnings soft patch
Public Storage (PSA) has hit a period of slower earnings growth, but the company still generates substantial operating cash, pays a reliable $3 quarte...
Southern Copper: Hold for Now but Protect Profits — Tail Risks Are Material
Strong cash flow and rising copper demand justify keeping exposure; set strict stops and scale targets to manage drawdown risk.
Southern Copper (SCCO) looks operationally healthy after the quarter ended 09/30/2025 — strong operating cash flow, growing quarterly profits, and a...
Motorcar Parts of America: This Ride Has Been Rough - Short Setup for a Swing Trade
High leverage, bloated inventory and outsized interest expense create a narrow path to upside — favor a tactical short.
Motorcar Parts (MPAA) shows improving top-line momentum but profits are being eaten by interest and tax items while inventory and liabilities remain e...
Meta in 2026: Buy the AI-ad Optionality on a Controlled Pullback (Upgrade)
Q4 beat, heavy taxes in Q3 were noise — fundamentals intact; trade the consolidation with defined risk.
Meta's Q4/2025 print showed the company continuing to monetize AI and expand revenue (01/28/2026). Q3/2025 included a large tax-related hit that maske...
GlobalFoundries: Positioning for Long-Cycle Growth as Reshoring Drives Demand
A tactical long trade around policy-driven capacity expansion, silicon-photonics M&A, and a refreshed management team
GlobalFoundries (GFS) is steering away from the cutthroat leading-edge node wars and toward long-cycle growth supported by reshoring, M&A in photonics...
UP Fintech: Treat the Soft Volume Quarter as a Pullback, Not a Death Knell
Short-term weakness in trading activity creates an asymmetric swing opportunity — entry, stop and two upside targets.
UP Fintech (TIGR) looks mispriced for a tactical long after a quarter of soft trading volumes pushed the stock lower. The platform still benefits from...
Travere (TVTX) — Why FILSPARI's FSGS Approval Is a More Likely Positive Black Swan Than Most Assume
An actionable long trade: entry, stops, targets and the data points that justify a higher-than-consensus approval probability for sparsentan in FSGS
Travere Therapeutics has a commercially proven asset in FILSPARI (sparsentan) for rare kidney disease; the company filed an sNDA for focal segmental g...
Ameriprise: Rate Anxiety Is Exhausted—Buy the Recovery Near $520
Q4 beat, rising cash generation and steady AUM make AMP a compelling short-term long; risk-managed entry and clear stops recommended.
Ameriprise (AMP) just proved that the late-cycle rate narrative is overstated. Strong cash flow, a clean beat in the recent quarter, and sustained div...